Historical record - last NADAC effective date: 3/23/2016
Product Information
VICKS NYQUIL SEVERE COLD-FLU is a brand product labeled by The Procter & Gamble Manufacturing Company, priced at $0.0293 per ML under NDC 37000081208. Its NADAC has been published 115 times since Jan 22, 2014.
VICKS NYQUIL SEVERE COLD-FLU
Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, and Phenylephrine HydrochlorideStrength
650; 20; 12.5; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL
Manufacturer
The Procter & Gamble Manufacturing CompanyNDC
37000081208
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
3/23/2016
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/22/2013
Pharmacological Classes
Price Statistics
The NADAC for VICKS NYQUIL SEVERE COLD-FLU has been published 115 times since Jan 22, 2014, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0293 per ML |
|---|---|
| All-time high | $0.0321 (Jan 14, 2015) |
| All-time low | $0.0256 (May 21, 2014) |
| Median price | $0.0298 |
| Average price | $0.0293 |
| Largest weekly change | +11.3% (Jun 25, 2014) |
| Weeks tracked | 115 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+6.6%
Last surveyed Mar 30, 2016 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VICKS NYQUIL SEVERE COLD-FLU?
The current National Average Drug Acquisition Cost (NADAC) for VICKS NYQUIL SEVERE COLD-FLU, manufactured by The Procter & Gamble Manufacturing Company, is $0.0293 per ML (NDC 37000081208), effective Mar 30, 2016.
How has the price of VICKS NYQUIL SEVERE COLD-FLU changed over time?
Over the history we have for it, the NADAC for VICKS NYQUIL SEVERE COLD-FLU has risen 6.6%. It has been tracked across 115 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for VICKS NYQUIL SEVERE COLD-FLU?
Since Jan 22, 2014, the NADAC for VICKS NYQUIL SEVERE COLD-FLU has ranged from a low of $0.0256 (May 21, 2014) to a high of $0.0321 (Jan 14, 2015), with a median of $0.0298 per ML.
Are there cheaper alternatives to VICKS NYQUIL SEVERE COLD-FLU?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VICKS NYQUIL SEVERE COLD-FLU, is $0.0235 per ML — about 20% below VICKS NYQUIL SEVERE COLD-FLU.
Who manufactures VICKS NYQUIL SEVERE COLD-FLU?
VICKS NYQUIL SEVERE COLD-FLU (NDC 37000081208) is labeled by The Procter & Gamble Manufacturing Company, and CMS classifies it as a brand product.